Page 104 - Williams Hematology ( PDFDrive )

80 Part II: The Organization of the Lymphohematopoietic Tissues Chapter 5: Structure of the Marrow and the Hematopoietic Microenvironment 81

291. Xie B, Laouar A, Huberman E: Fibronectin-mediated cell adhesion is required for 323. Bonig H, Chang K-H, Nakamoto B, Papayannopoulou T: The p67 laminin receptor
induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during identifies human erythroid progenitor and precursor cells and is functionally impor-
macrophage differentiation. The signaling role of protein kinase C-beta. J Biol Chem tant for their bone marrow lodgment. Blood 108:1230, 2006.
273:11576, 1998. 324. El Nemer W, Gane P, Colin Y, et al: The Lutheran blood group glycoproteins, the ery-
292. Kremlev SG, Chapoval AI, Evans R: Cytokine release by macrophages after interact- throid receptors for laminin, are adhesion molecules. J Biol Chem 273:16686, 1998.
ing with CSF-1 and extracellular matrix proteins: Characteristics of a mouse model of 325. Ohki K, Kohashi O: Laminin promotes proliferation of bone marrow-derived macro-
inflammatory responses in vitro. Cell Immunol 185:59, 1998. phages and macrophage cell lines. Cell Struct Funct 19:63, 1994.
293. Yonezawa I, Kato K, Yagita H, et al: VLA-5-mediated interaction with fibronectin 326. Fehlner-Gardiner C, Uniyal S, von Ballestrem C, et al: Integrin VLA-6 (alpha 6 beta
induces cytokine production by human chondrocytes. Biochem Biophys Res Commun 1) mediates adhesion of mouse bone marrow-derived mast cells to laminin. Allergy
219:261, 1996. 51:650, 1996.
294. Chiquet-Ehrismann R, Matsuoka Y, Hofer U, et al: Tenascin variants: Differential bind- 327. Bornstein P: Thrombospondins as matricellular modulators of cell function. J Clin
ing to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul 2:927, Invest 107:929, 2001.
1991. 328. Long MW, Dixit VM: Thrombospondin functions as a cytoadhesion molecule for
295. Seiffert M, Beck SC, Schermutzki F, et al: Mitogenic and adhesive effects of tenascin-C human hematopoietic progenitor cells. Blood 75:2311, 1990.
on human hematopoietic cells are mediated by various functional domains. Matrix Biol 329. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al: Thrombospondin-1 is a major acti-
17:47, 1998. vator of TGF-beta1 in vivo. Cell 93:1159, 1998.
296. Ohta M, Sakai T, Saga Y, et al: Suppression of hematopoietic activity in tenascin-C- 330. Pierson BA, Gupta K, Hu WS, Miller JS: Human natural killer cell expansion is reg-
deficient mice. Blood 91:4074, 1998. ulated by thrombospondin-mediated activation of transforming growth factor-beta 1
297. Nakamura-Ishizu A, Okuno Y, Omatsu Y, et al: Extracellular matrix protein tenascin-C and independent accessory cell-derived contact and soluble factors. Blood 87:180, 1996.
is required in the bone marrow microenvironment primed for hematopoietic regener- 331. Delany AM, Hankenson KD: Thrombospondin-2 and SPARC/osteonectin are critical
ation. Blood 119:5429, 2012. regulators of bone remodeling. J Cell Commun Signal 3:227, 2009.
298. Mackie EJ, Tucker RP: The tenascin-C knockout revisited. J Cell Sci 112:3847, 1999. 332. Bailey Dubose K, Zayzafoon M, Murphy-Ullrich JE: Thrombospondin-1 inhibits oste-
299. Bentley SA: Collagen synthesis by bone marrow stromal cells: A quantitative study. Br J ogenic differentiation of human mesenchymal stem cells through latent TGF-beta acti-
Haematol 50:491, 1982. vation. Biochem Biophys Res Commun 422:488, 2012.
300. Mori M, Sadahira Y, Kawasaki S, et al: Formation of capillary networks from bone mar- 333. Li WX, Howard RJ, Leung LL: Identification of SVTCG in thrombospondin as the
row cultured in collagen gel. Cell Struct Funct 14:393, 1989. conformation-dependent, high affinity binding site for its receptor, CD36. J Biol Chem
301. Zuckerman KS, Rhodes RK, Goodrum DD, et al: Inhibition of collagen deposition in 268:16179, 1993.
the extracellular matrix prevents the establishment of a stroma supportive of hemato- 334. Calvo D, Vega MA: Identification, primary structure, and distribution of CLA-1, a
poiesis in long-term murine bone marrow cultures. J Clin Invest 75:970, 1985. novel member of the CD36/LIMPII gene family. J Biol Chem 268:18929, 1993.
302. Leisten I, Kramann R, Ventura Ferreira MS, et al: 3D co-culture of hematopoietic stem 335. Nakahata T, Okumura N: Cell surface antigen expression in human erythroid progeni-
and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the tors: Erythroid and megakaryocytic markers. Leuk Lymphoma 13:401, 1994.
hematopoietic niche. Biomaterials 33:1736, 2012. 336. Qian X, Wang TN, Rothman VL, et al: Thrombospondin-1 modulates angiogenesis in
303. Chichester CO, Fernández M, Minguell JJ: Extracellular matrix gene expression by vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp Cell Res
human bone marrow stroma and by marrow fibroblasts. Cell Adhes Commun 1:93, 235:403, 1997.
1993. 337. Mansfield PJ, Suchard SJ: Thrombospondin promotes chemotaxis and haptotaxis of
304. Klein G, Muller CA, Tillet E, et al: Collagen type VI in the human bone marrow micro- human peripheral blood monocytes. J Immunol 153:4219, 1994.
environment: A strong cytoadhesive component. Blood 86:1740, 1995. 338. Taraboletti G, Belotti D, Borsotti P, et al: The 140-kilodalton antiangiogenic fragment
305. Koenigsmann M, Griffin JD, DiCarlo J, Cannistra SA: Myeloid and erythroid progeni- of thrombospondin-1 binds to basic fibroblast growth factor. Cell Growth Differ 8:471,
tor cells from normal bone marrow adhere to collagen type I. Blood 79:657, 1992. 1997.
306. Klein G, Kibler C, Schermutzki F, et al: Cell binding properties of collagen type XIV for 339. Margosio B, Marchetti D, Vergani V, et al: Thrombospondin 1 as a scavenger for matrix
human hematopoietic cells. Matrix Biol 16:307, 1998. -associated fibroblast growth factor 2. Blood 102:4399, 2003.
307. Nilsson SK, Debatis ME, Dooner MS, et al: Immunofluorescence characterization of 340. Kyriakides TR, Rojnuckarin P, Reidy MA, et al: Megakaryocytes require thrombospondin-2
key extracellular matrix proteins in murine bone marrow in situ. J Histochem Cytochem for normal platelet formation and function. Blood 101:3915, 2003.
46:371, 1998. 341. Sadvakassova G, Dobocan MC, Difalco MR, Congote LF: Regulator of differentiation
308. Malara A, Gruppi C, Pallotta I, et al: Extracellular matrix structure and nano-mechanics 1 (ROD1) binds to the amphipathic C-terminal peptide of thrombospondin-4 and is
determine megakaryocyte function. Blood 118:4449, 2011. involved in its mitogenic activity. J Cell Physiol 220:672, 2009.
309. Abbonante V, Gruppi C, Rubel D, et al: Discoidin domain receptor 1 protein is a novel 342. Leavesley DI, Kashyap AS, Croll T, et al: Vitronectin—master controller or microman-
modulator of megakaryocyte-collagen interactions. J Biol Chem 288:16738, 2013. ager? IUBMB Life 65:807, 2013.
310. Kleinman HK, Weeks BS: Laminin: Structure, functions and receptors. Curr Opin Cell 343. Boissy P, Machuca I, Pfaff M, et al: Aggregation of mononucleated precursors triggers
Biol 1:964, 1989. cell surface expression of alphavbeta3 integrin, essential to formation of osteoclast-like
311. Senior RM, Gresham HD, Griffin GL, et al: Entactin stimulates neutrophil adhesion multinucleated cells. J Cell Sci 111:2563, 1998.
and chemotaxis through interactions between its Arg-Gly-Asp (RGD) domain and the 344. Mbalaviele G, Jaiswal N, Meng A, et al: Human mesenchymal stem cells promote
leukocyte response integrin. J Clin Invest 90:2251, 1992. human osteoclast differentiation from CD34+ bone marrow hematopoietic progeni-
312. Bryant G, Rao CN, Brentani M, et al: A role for the laminin receptor in leukocyte che- tors. Endocrinology 140:3736, 1999.
motaxis. J Leukoc Biol 41:220, 1987. 345. Poujol C, Nurden AT, Nurden P: Ultrastructural analysis of the distribution of the vit-
313. Lundgren-Akerlund E, Olofsson AM, Berger E, Arfors KE: CD11b/CD18-dependent ronectin receptor (alpha v beta 3) in human platelets and megakaryocytes reveals an
polymorphonuclear leucocyte interaction with matrix proteins in adhesion and migra- intracellular pool and labelling of the alpha-granule membrane. Br J Haematol 96:823,
tion. Scand J Immunol 37:569, 1993. 1997.
314. Gu YC, Kortesmaa J, Tryggvason K, et al: Laminin isoform-specific promotion of adhe- 346. Shimizu Y, Irani AM, Brown EJ, et al: Human mast cells derived from fetal liver cells
sion and migration of human bone marrow progenitor cells. Blood 101:877, 2003. cultured with stem cell factor express a functional CD51/CD61 (alpha v beta 3) integ-
315. Tobias JW, Bern MM, Netland PA, Zetter BR: Monocyte adhesion to subendothelial rin. Blood 86:930, 1995.
components. Blood 69:1265, 1987. 347. Weerasinghe D, McHugh KP, Ross FP, et al: A role for the alphavbeta3 integrin in the
316. Bohnsack JF: CD11/CD18-independent neutrophil adherence to laminin is mediated transmigration of monocytes. J Cell Biol 142:595, 1998.
by the integrin VLA-6. Blood 79:1545, 1992. 348. Rainger GE, Buckley CD, Simmons DL, Nash GB: Neutrophils sense flow-generated
317. Bohnsack JF, Akiyama SK, Damsky CH, et al: Human neutrophil adherence to laminin stress and direct their migration through alphaVbeta3-integrin. Am J Physiol 276:H858,
in vitro. Evidence for a distinct neutrophil integrin receptor for laminin. J Exp Med 1999.
171:1221, 1990. 349. Savill J, Hogg N, Ren Y, Haslett C: Thrombospondin cooperates with CD36 and the
318. Gu Y, Sorokin L, Durbeej M, et al: Characterization of bone marrow laminins and iden- vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J
tification of alpha5-containing laminins as adhesive proteins for multipotent hemato- Clin Invest 90:1513, 1992.
poietic FDCP-Mix cells. Blood 93:2533, 1999. 350. Fadok VA, Warner ML, Bratton DL, Henson PM: CD36 is required for phagocytosis of
319. Vogel W, Kanz L, Brugger W, et al: Expression of laminin beta2 chain in normal human apoptotic cells by human macrophages that use either a phosphatidylserine receptor or
bone marrow. Blood 94:1143, 1999. the vitronectin receptor (alpha v beta 3). J Immunol 161:6250, 1998.
320. Siler U, Rousselle P, Muller CA, Klein G: Laminin gamma2 chain as a stromal cell 351. Rubartelli A, Poggi A, Zocchi MR: The selective engulfment of apoptotic bodies by
marker of the human bone marrow microenvironment. Br J Haematol 119:212, 2002. dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and
321. Qian H, Tryggvason K, Jacobsen SE, Ekblom M: Contribution of alpha6 integrins to extracellular calcium. Eur J Immunol 27:1893, 1997.
hematopoietic stem and progenitor cell homing to bone marrow and collaboration with 352. Zheng X, Saunders TL, Camper SA, et al: Vitronectin is not essential for normal mam-
alpha4 integrins. Blood 107:3503, 2006. malian development and fertility. Proc Natl Acad Sci U S A 92:12426, 1995.
322. Selleri C, Ragno P, Ricci P, et al: The metastasis-associated 67-kDa laminin receptor 353. Jang YC, Tsou R, Gibran NS, Isik FF: Vitronectin deficiency is associated with increased
is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood 108:2476, wound fibrinolysis and decreased microvascular angiogenesis in mice. Surgery 127:696,
2006. 2000.

Kaushansky_chapter 05_p0051-0084.indd 80 9/19/15 12:11 AM